Ohio Lethal Injections Need Drugmaker Protection, Says AG

Ohio Lethal Injections Need Drugmaker Protection, Says AG

time.com/.../ohio-lethal-injection-secrecy-law-drugs/?...

Time

12 hours ago - Like most states, the Ohio Department of Rehabilitation and Correction is attempting to acquire drugs from compounding pharmacies, which are not regulated by  ...

5 Things You Need to Know About Where Rx Drugs Come ..

5 Things You Need to Know About Where Rx Drugs Come ...  

www.thenationworld.com/5-things-need-know-rx-drugs-come.html

7 hours ago - Compounding pharmacies are legal, but are not FDA-regulated. Unlike traditional pharmacies, which dispense drugs manufactured by drug companies,  ...

EmlemHealth Announces Changes with list of excluded compounded drugs and their commercially available, FDA-Approved alternatives

Change to Compounded Drug Coverage - EmblemHealth  
www.emblemhealth.com/.../Change-to-Compounded-Dru...



EmblemHealth
9 hours ago - Click on the link below to see a list of the most frequently prescribed excluded compounded drugs and their commercially available, FDA-approved alternatives.

Updated list of FDA 483s issued in 2014 (10/1/2014)

• Advanced Pharma Inc., Houston, TX, 483 Issued 3/17/2014 (PDF - 638KB)
• Alexander Infusion, LLC dba Avanti Health Care Services, New Hyde Park, NY, 483 Issued 7/9/2014 (PDF - 1.4MB)
• AnazaoHealth Corporation, Tampa, FL, Referral Letter to FL BOP Issued 2/21/2014 (PDF - 375KB)
• Browns Compounding Center, Inc., Englewood, CO, 483 Issued 8/11/2014 (PDF - 580KB)
• Central Admixture Pharmacy Services, Inc. (CAPS), San Diego, CA, 483 Issued 8/8/2014 (PDF - 1.5MB)
• Central Admixture Pharmacy Services, Inc. (CAPS), Livonia, MI, 483 Issued 6/25/2014 (PDF - 928KB)
• Central Admixture Pharmacy Services, Inc. (CAPS), Allentown, PA, 483 Issued 6/11/2014 (PDF - 2.1MB)
• Central Admixture Pharmacy Services, Inc. (CAPS), Woburn, MA, 483 Issued 2/20/2014 (PDF - 1.9MB)
• Complete Pharmacy and Medical Solutions, LLC, Miami Lakes, FL, 483 Issued 8/12/2014 (PDF - 1.4MB)
• DNA Pharmacy Services Inc dba Palm Beach Compounding, Jupiter, FL, 483 Issued 8/13/2014 (PDF - 251KB)
• Downing Labs, LLC (formerly NuVision Pharmacy, Inc), Dallas, TX, FDA Requested Recall Letter Issued 9/9/2014 (PDF - 941KB)
• Downing Labs, LLC (formerly NuVision Pharmacy, Inc), Dallas, TX, 483 Issued 7/16/2014 (PDF - 2.1MB)
• Eastern Pharmacy, Inc., Ocala, FL, 483 Issued 2/4/2014 (PDF - 516KB)
• Foundation Care, LLC, Earth City, MO, Referral Letter to MO Board of Pharmacy Issued 2/26/2014 (PDF - 396KB)
• Franck's Lab Inc dba Trinity Care Solutions, Ocala, FL, 483 Issued 5/23/2014 (PDF - 856KB)
• Healix Infusion Therapy, Inc., Sugar Land, TX, 483 Issued 5/16/2014 (PDF - 628KB)
• Health Dimensions Inc., Farmington Hills, MI, 483 Issued 8/8/2014 (PDF - 613KB)
• HHCS Pharmacy, Inc. dba Freedom Pharmacy, Orlando, FL, 483 Issued 7/28/2014 (PDF - 1.7MB)
• Hopewell Pharmacy, Hopewell, NJ, Referral Letter to NJ Board of Pharmacy Issued 2/21/2014 (PDF - 1.3MB)
• Infusion Options, Inc., Brooklyn, NY, 483 Issued 4/23/2014 (PDF - 2.3MB)
• I.V. Specialty Ltd., Austin, TX, 483 Issued 7/22/2014 (PDF - 1019KB)
• John W. Hollis Inc dba John Hollis Pharmacy, Nashville, TN, 483 Issued 3/21/2014 (PDF - 1.3MB)
• Kings Park Slope, Inc., Brooklyn, NY, 483 Issued 3/14/2014 (PDF - 3.2MB)
• KRS Global Biotechnology, Inc., Boca Raton, FL, 483 Issued 3/17/2014 (PDF - 735KB)
• LeeSar, Inc., Fort Myers, FL, 483 Issued 8/8/2014 (PDF - 541KB)
• Leiter's Cambrian Park Drugs, Inc., dba Leiter's Pharmacy, San Jose, CA, 483 Issued 3/6/2014 (PDF - 1.3MB)
• Leiter's Compounding Pharmacy, San Jose, CA, 483 Response Dated 3/26/2014 (PDF - 3.6MB)
• Lowlyn Pharmacies, Inc., d/b/a Red Cross Drug, Blanchard, OK, Referral Letter to OK Board of Pharmacy Issued 2/25/2014 (PDF - 2.4MB)
• Martin Avenue Pharmacy, Inc., Naperville, IL, 483 Issued 7/21/2014 (PDF - 1.8MB)
• Nebraska Methodist Hospital, Omaha, NE, 483 Issued 7/14/2014 (PDF - 772KB)
• Nora Apothecary and Alternative Therapies, Inc., Indianapolis, IN, 483 Issued 8/21/2014 (PDF - 422KB)
• One Way Drug, LLC dba Partell Specialty Pharmacy, Las Vegas, NV, 483 Issued 5/30/2014 (PDF - 1.3MB)
• People’s Pharmacy, Inc. #2, Austin, TX, 483 Issued 7/28/2014 (PDF - 560KB)
• Pharmakon Pharmaceuticals, Inc. Noblesville, IN, 483 Issued 3/13/2014 (PDF - 1.9MB)
• Pharmakon Pharmaceuticals, Noblesville, IN, 483 Issued 4/8/2014 (PDF - 350KB)
• Portage Pharmacy Inc., Portage, MI, Referral Letter to MI Board of Pharmacy Issued 2/25/2014 (PDF - 357KB)
• Premier Pharmacy Labs, Inc., Weeki Wachee, FL, 483 Issued 5/9/2014 (PDF - 2.5MB)
• Region Care, Inc., Great Neck, NY, 483 Issued 3/20/2014 (PDF - 922KB)
• RX South LLC DBA RX3 Pharmacy, Chester, VA, 483 Issued 2/21/2014 (PDF - 5MB)
• SCA Pharmaceuticals, LLC, Little Rock, AR, 483 Issued 4/1/2014 (PDF - 1.7MB)
• South Coast Specialty Compounding, Inc. (Park Pharmacy and Compounding), Irvine, CA, 483 Issued 7/2/2014 (PDF - 708KB)
• Stewart Compounding Pharmacy, Fayetteville, NC, 483 Issued 2/26/2014 (PDF - 1.4MB)
• Transdermal Therapeutics, Inc, Birmingham, AL, 483 Issued 6/27/2014 (PDF - 413KB)
• Unique Pharmaceuticals, Ltd. FDA Requested Recall Letter Issued 7/11/2014 (PDF - 754KB)
• Unique Pharmaceuticals Ltd., Temple, TX, 483 Issued 6/20/2014 (PDF - 1MB)
• Unique Pharmaceutical, Ltd., Temple, TX, Amended 483 Issued 4/4/2014 (PDF - 4.3MB)
• Unique Pharmaceutical, Ltd., Temple, TX, 483 Issued 4/2/2014 (PDF - 748KB)
• University Pharmacy, Inc., Salt Lake City, UT, Referral Letter to UT Board of Pharmacy Issued 2/20/2014 (PDF - 240KB)
• US Compounding Inc., Conway, AR, 483 Issued 3/27/2014 (PDF - 1.1MB)
• Wells Pharmacy Network LLC, Ocala, FL, 483 Issued 6/19/2014 (PDF - 1MB)
• Wells Pharmacy Network LLC, Ocala, FL, 483 Issued 3/7/2014 (PDF - 1.2MB)
• Zions RX Formulations Services LLC dba Rx Formulation Serv., Mesa, AZ, 483 Issued 1/9/2014 (PDF - 1MB)

Updated List of FDA 483s issued in 2013 as of those released and posted by FDA as of October 1, 2014

• Abrams Royal Pharmacy, Dallas, TX, 483 Issued 12/20/2013 (PDF - 1.7MB)
• Allergy Laboratories, Inc., Oklahoma City, OK, 483 Issued 4/26/2013 (PDF - 4MB)
• Americare Compounding, LLC., Garden City South, NY, 483 Issued 6/19/2013 (PDF - 754KB)
• Anazaohealth Corporation, Tampa, FL, 483 Issued 2/22/2013 (PDF - 1.5MB)
• Apothecure, Inc., Dallas, TX, 483 Issued 4/17/2013 (PDF - 3.9MB)
• ARL Biopharma, Inc. dba Analytical Research Laboratories, Oklahoma City, OK, 483 Issued 11/8/2012 (PDF - 382KB)
• Avella of Deer Valley, Inc, Phoenix, AZ, 483 Issued 2/25/2013 (PDF - 1.2MB)
• Axium Healthcare Pharmacy (dba Balanced Solutions Compounding), Lake Mary, FL, 483 Issued 3/15/2013 (PDF - 638KB)
• Beacon Hill Medical Pharmacy, P.C., Southfield, MI, 483 Issued 7/19/2013 (PDF - 2.7MB)
• Blue Ridge Pharmacy and Compounding Center, Raleigh, NC, 483 Issued 10/23/2013 (PDF - 1.3MB)
• Boston Analytical, Inc., Salem, NH, 483 Issued 11/9/2012 (PDF - 490KB)
• Brookfield Prescription Center dba MD Custom Rx, Brookfield, WI, 483 Issued 12/13/2013 (PDF - 1.8MB)
• Cantrell Drug Company, Little Rock, AR, Amended 483 Issued 11/4/2013 (PDF - 6.5MB)
• Central Admixture Pharmacy Services, Inc., (CAPS), Chicago, IL, 483 Issued 2/22/2013 (PDF - 545KB)
• Central Admixture Pharmacy Services, Inc. (CAPS), Homewood, AL, 483 Issued 3/7/2013 (PDF - 600KB)
• Central Admixture Pharmacy Services, Inc., (CAPS), Kansas City, MO, 483 Issued 2/28/2013 (PDF - 1.1MB)
• Central Admixture Pharmacy Services, Inc., (CAPS), Livonia, MI, 483 Issued 2/22/2013 (PDF - 1.5MB)
• Central Admixture Pharmacy Services, Inc., (CAPS), Livonia, MI, 483 Issued 2/28/2013 (PDF - 1.5MB)
• Central Admixture Pharmacy Services, Inc. (CAPS), Wallingford, CT, 483 Issued 2/19/2013 (PDF - 3.2MB)
• Central Admixture Pharmacy Services, Inc. (CAPS), Woburn, MA, 483 Issued 1/29/2013 (PDF - 3MB)
• Clinical Apothecaries, Medina, OH, 483 Issued 11/20/2013 (PDF - 660KB)
• Clinical Specialties Compounding Pharmacy, Augusta, GA, 483 Issued 4/2/2013 (PDF - 1.6MB)
• College Pharmacy Incorporated, Colorado Springs, CO, 483 Issued 3/15/2013 (PDF - 1.9MB)
• The Compounding Shop, Inc., St. Petersburg, FL, 483 Issued 9/3/2013 (PDF - 105KB)
• The Compounding Shop St. Petersburg, FL, 483 Issued 3/22/2013 (PDF - 1.3MB)
• The Compounding Shop St. Petersburg, FL, Amended 483 Issued 3/25/2013 (PDF - 10MB)
• Custom Compounding Center, Los Alamitos, CA, 483 Issued 12/13/2012 (PDF - 1.2MB)
• Delta Pharma, Inc., Ripley, MS, 483 Issued 10/2/2013 (PDF - 1.4MB)
• Diamondback Drugs of Delaware, LLC, Scottsdale, AZ, 483 Issued 5/17/2013 (PDF - 1.1MB)
• Drugs are Us, Inc. (dba Hopewell Pharmacy), Hopewell, NJ, 483 Issued 3/21/2013 (PDF - 532KB)
• Dyna Labs, LLC, St. Louis, MO, 483 Issued 11/13/2012 (PDF - 961KB)
• Eagle Analytical Lab, Houston, TX, 483 Responses dated 7/9/2013 (PDF - 8.4MB)
• Eagle Analytical Services, Houston, TX, 483 Issued 6/17/2013 (PDF - 179KB)
• Foundation Care LLC, Earth City, MO, 483 Issued 3/19/2013 (PDF - 1.4MB)
• Foundation Care LLC, Earth City, MO, 483 Response Dated 4/9/2013 (PDF - 1.1MB)
• Front Range Laboratories, Incorporated, Loveland, CO, 483 Issued 8/30/2013 (PDF - 3.5MB)
• FVS Holdings, Inc. (dba Green Valley Drugs), Henderson, NV, 483 Issued 3/15/2013 (PDF - 1.4MB)
• Grandpa's Compounding Pharmacy, Inc., Placerville, CA, 483 Issued 9/10/2013 (PDF - 4.1MB)
• Greer Laboratories, Inc., Lenoir, NC, 483 Issued 11/15/2013 (PDF - 1.9MB)
• Home Infusions Solutions, Inc., Horsham, PA, 483 Issued 5/21/2013 (PDF - 1.3MB)
• Home Intensive Care Pharmacy, Inc., San Antonio, TX, 483 Issued 3/1/2013 (PDF - 443KB)
• IV Solutions of Lubbock, Lubbock, TX, 483 Issued 3/20/2013 (PDF - 798KB)
• IV Solutions of Lubbock, Lubbock, TX, 483 Response Dated 4/2/2013 (PDF - 929KB)
• JCB Labs, LLC, Wichita, KS, 483 Issued 2/27/2013 (PDF - 483KB)
• Lee and Company dba Lee Pharmacy, Inc., Fort Smith, AR, 483 Issued 2/21/2013 (PDF - 619KB)
• Leiter's Cambrian Park Drugs, Inc., dba Leiter's Pharmacy, San Jose, CA, 483 Issued 11/5/2013 (PDF - 3.8MB)
• Leiter's Compounding Pharmacy, San Jose, CA, 483 Response Dated 11/25/2013 (PDF - 5MB)
• Lowlite Investments, Inc. (dba Olympia Pharmacy), Orlando, FL, 483 Issued 3/21/2013 (PDF - 1.6MB)
• Lowlyn Pharmacies, Inc., Blanchard, OK, 483 Issued 3/8/2013 (PDF - 732KB)
• Main Street Family Pharmacy, LLC, Newbern, TN, 483 Issued 6/11/2013 (PDF - 1.9MB)
• Medaus, Inc., Birmingham, AL, 483 Issued 3/22/2013 (PDF - 1.5MB)
• Medi-fare Drug and Home Health Center, Blacksburg, SC, 483 Issued 6/21/2013 (PDF - 2.4MB)
• Medi-Fare Drug & Home Health Center, Inc., Blacksburg, SC, 483 Issued 1/18/2013 (PDF - 1.1MB)
• MedPREP Consulting Inc., Tinton Falls, NJ, 483 Issued 4/3/2013 (PDF - 2.2MB)
• Nature's Pharmacy & Compounding Center, Asheville, NC, 483 Issued 11/22/2013 (PDF - 1MB)
• Nora Apothecary and Alternative Therapies, Inc., Indianapolis, IN, 483 Issued 3/21/2013 (PDF - 623KB)
• NuVision Pharmacy, Inc., Dallas, TX, FDA Requested Recall Letter Issued 7/26/2013 (PDF - 797KB)
• NuVision Pharmacy, Inc., Dallas, TX, 483 Issued 4/17/2013 (PDF - 2.8MB)
• Oakdell Pharmacy, Inc., San Antonio, TX, 483 Issued 3/1/2013 (PDF - 817KB)
• Pallimed Solutions, Inc., Woburn, MA, Amended 483 and Cover Letter Issued 4/9/2013 and 483 Issued 3/29/2013 (PDF - 3.3MB)
• Pentec Health, Inc., Boothwyn, PA, 483 Issued 4/1/2013 (PDF - 2MB)
• PharMEDium Services, LLC, Cleveland, MS, 483 Issued 2/22/2013 (PDF - 796KB)
• PharMEDium Services LLC, Edison, NJ, 483 Issued 2/28/2013 (PDF - 541KB)
• PharMEDium Services LLC, Memphis, TN, 483 Issued 3/22/2013 (PDF - 1.3MB)
• PharMEDium Service, Inc., Sugarland, TX, 483 Issued 2/27/2013 (PDF - 1.7MB)
• Pharmacy Creations, LLC, Randolph, NJ, 483 Response Issued 9/3/2013 (PDF - 39KB)
• Pharmacy Creations, Randolph, NJ, 483 Issued 8/19/2013 (PDF - 368KB)
• Pharmagen Laboratories, Inc, Stamford, CT, Amended 483 Issued 08/26/2013 (PDF - 2.6MB)
• Pharmagen Laboratories, Inc, Stamford, CT, 483 Issued 08/23/2013 (PDF - 2.5MB)
• Pine Pharmacy and Home Care Products Center, Inc., Williamsville, NY, 483 Issued 12/16/2013 (PDF - 848KB)
• Pine Pharmacy and Home Care Products Center, Inc., Williamsville, NY, 483 Issued 7/19/2013 (PDF - 1.4MB)
• Portage Pharmacy, Inc., Portage, MI, 483 Issued 3/6/2013 (PDF - 1.5MB)
• RC Compounding Services, LLC, Poland, OH, 483 Issued 2/7/2013 (PDF - 209KB)
• RxSouth, LLC (dba RX3 Pharmacy), Chester, VA, Referral Letter to VA Board of Pharmacy Issued 8/13/2013 (PDF - 2.6MB)
• RxSouth, LLC (dba RX3 Pharmacy), Chester, VA, 483 Issued 12/14/2012 (PDF - 1.7MB)
• Specialty Compounding, LLC, Cedar Park, TX, 483 Issued 9/13/2013 (PDF - 3.4MB)
• Specialty Compounding Pharmacy, Cedar Park, TX, 483 Issued 3/22/2013 (PDF - 744KB)
• Specialty Medicine Compounding Pharmacy, P.C., South Lyon, MI, 483 Issued 11/5/2013 (PDF - 3.2MB)
• Stewart Compounding Pharmacy, Fayetteville, NC, 483 Issued 3/25/2013 (PDF - 1.7MB)
• Total Pharmacy Services, Inc., Houma, LA, 483 Issued 5/22/2013 (PDF - 713KB)
• Triangle Compounding, Cary, NC, 483 Issued 3/1/2013 (PDF - 880KB)
• University Pharmacy, Inc., Salt Lake City, UT, 483 Issued 2/26/2013 (PDF - 1.4MB)
• Village Fertility Pharmacy, Inc., Waltham, MA, 483 Issued 3/13/2013 (PDF - 553KB)
• Wedgewood Village Pharmacy, Inc. Swedesboro, NJ, 483 Issued 2/11/2013 (PDF - 3.4MB)
• Wells Pharmacy Network LLC, Ocala, FL, 483 Issued 07/26/2013 (PDF - 1.1MB)
• Wiley Chemists, Inc., Santa Fe, NM, 483 Issued 10/2/2013 (PDF - 535KB)

Nora Apothecary and Alternative Therapies, Inc., Indianapolis, IN, FDA 483 Issued 8/21/2014 (PDF - 422KB)

• Nora Apothecary and Alternative Therapies, Inc., Indianapolis, IN, 483 Issued 8/21/2014 (PDF - 422KB)

Health Dimensions Inc., Farmington Hills, MI, 483 Issued 8/8/2014 (PDF - 613KB)

• Health Dimensions Inc., Farmington Hills, MI, 483 Issued 8/8/2014 (PDF - 613KB)

DNA Pharmacy Services Inc dba Palm Beach Compounding, Jupiter, FL, 483 Issued 8/13/2014 (PDF - 251KB)

• DNA Pharmacy Services Inc dba Palm Beach Compounding, Jupiter, FL, 483 Issued 8/13/2014 (PDF - 251KB)

Browns Compounding Center, Inc., Englewood, CO, FDA 483 Issued 8/11/2014 (PDF - 580KB)

• Browns Compounding Center, Inc., Englewood, CO, 483 Issued 8/11/2014 (PDF - 580KB)

Complete Pharmacy and Medical Solutions, LLC, Miami Lakes, FL, FDA 483 Issued 8/12/2014 (PDF - 1.4MB)

• Complete Pharmacy and Medical Solutions, LLC, Miami Lakes, FL, 483 Issued 8/12/2014 (PDF - 1.4MB)

More Kudos for Oklahoma State Board of Pharmacy Regarding Recent Disciplinary Action Against Compounding Pharmacies and Pharmacists

Quantum Medical, Inc, #3-4367 – Case No. 1285: Admitted

to guilt on 28 counts including failing to meet United States

Pharmacopeia (USP) Compounding Standards and Board rules

for sterile compounding; failing to establish and maintain effective

controls against diversion; failing to supervise employees

as they relate to the practice of pharmacy; allowing someone

other than a pharmacist to unlock the pharmacy area; allowing

prescription medications to be left outside the prescription

area when the pharmacist is not in attendance; failing to have

an area designated for the preparation of sterile therapeutic

preparations; failing to have a sink with hot and cold running

water that is convenient to the compounding area; allowing a

person to have access to the parenteral pharmacy in the absence

of an Oklahoma-registered pharmacist; failing to have a documented,

ongoing quality assurance program; failing to ensure

that all compounders who compound pharmaceuticals meet

all requirements for training, testing, and education; failing

to have available for inspection completed documentation of

pharmacist-supervised training and testing in product preparation

of pharmacy technicians participating in the preparation

of compounded products; preparing an inordinate amount of

products in anticipation of a prescription prior to receiving a

valid prescription; failing to properly label and store hazardous

drugs; failing to require that all staff wear personnel protective

equipment (PPE) while working with hazardous drugs;

failing to make the required facility improvements within the

time required; failing to require a technician to have received a

pharmacy technician permit before performing any of the duties

of pharmacy technicians; failing to document training of a currently

permitted technician within 10 days of hire; and placing

drugs with a home care agency, pursuant to agreement, that are 

not allowed by Board rules. Parenteral (sterile compounding)

permit is suspended. Must provide sterile and nonsterile

compounding policies and procedures manual to Board for

approval prior to being allowed to compound. $7,500 fine.

James Casebeer, DPh, #10740 – Case No. 1286: Admitted to

guilt on 32 counts including failing to meet USP Compounding

Standards and Board rules for sterile compounding; failing

to establish and maintain effective controls against diversion;

failing to supervise employees as they relate to the practice of

pharmacy; allowing someone other than a pharmacist to unlock

the pharmacy area; allowing prescription medications to be

left outside the prescription area when the pharmacist is not in

attendance; allowing a person to have access to the parenteral

pharmacy in the absence of an Oklahoma-registered pharmacist;

failing to have a documented, ongoing quality assurance

program; failing to have available for inspection completed

documentation of pharmacist-supervised training and testing

in product preparation of pharmacy technicians participating

in the preparation of compounded products; preparing an inordinate

amount of products in anticipation of a prescription

prior to receiving a valid prescription; failing to properly label

and store hazardous drugs; failing to require that all staff wear

PPE while working with hazardous drugs; failing to make the

required facility improvements within the time required; failing

to document training of a currently permitted technician

within 10 days of hire; and placing drugs with a home care

agency, pursuant to agreement, that are not allowed by Board

rules. Placed on probation for five years until June 12, 2019.

$5,000 fine. Must successfully complete both sterile and

nonsterile compounding education approved by the Board,

and show that his resumed compounding would not put

the public at risk before doing either sterile or nonsterile

compounding. Shall attend a one-day (eight-hour) law

seminar in addition to the required 15 hours of continuing

education (CE) during the calendar years of 2014 and 2015.

All CE required for license renewal shall be live during the

five years of probation.

South Dakota Board of Pharmacy October 2014 Newsletter

here

Oklahoma Board of Pharmacy October 2014 Newsletter--Major Disciplinary Action Against Compounders

here

NABP Newsletter October 2014

here

New Jersey Board of Pharmacy October 2014 Newsletter with Details of New Compounding State Laws

here

Arizona Board of Pharmacy October 2014 Newsletter--including disciplinary action

here

Louisiana Board of Pharmacy October 2014 Newsletter--important law changes federal and state

here

Montana Board of Pharmacy October 2014 Newsletter

here

Kudos to Oklahoma Board of Pharmacy for Disciplinary Action against OK Compounding --6535 counts--admitted guilt to one count--3 years probation; $520,200 fine!!! No business allowed for 5 days

OK Compounding, LLC, #2-6161 – Case No. 1268: Admitted
to guilt on one count and neither admits nor denies guilt on the
remaining 6,535 counts including, but not limited to, employee
training, record keeping, proper billing for services, properly
licensed staff, unlicensed interstate sales, failing to perform
and document an adequate final check of preparations prior to
their release from the pharmacy, and failing to have available
written policies and procedures for all steps in the compounding
of preparations. Placed on probation for three years until
April 16, 2017. $520,200 fine. Must cease business operations
and fill no prescriptions for five full days between
June 12, 2014 and July 21, 2014.

Nevada Board of Pharmacy October 2014 Newsletter

here

Pine Pharmacy invests $1M to fill drug distribution void Oct 1, 2014, 10:37am EDT

http://www.bizjournals.com/buffalo/news/2014/10/01/pine-pharmacy-invests-1m-to-fill-drug-distribution.html

BREAKING NEWS!! Coverage revised for compound drugs prescribed for Medicare-eligible IHCP members Effective November 1, 2014, the Indiana Health Coverage Programs (IHCP) is revising its coverage policy for extemporaneously compounded drug products prescribed for IHCP members who are also eligible for Medicare Part D coverage. Compounded drug products containing a Medicare Part D-covered drug product will not be covered by the IHCP for dually eligible members. This change applies to dates of service on or after November 1, 2014.

more information found here

APOTECA To Engage In A Unique Enterprise Solution For IV Automation At The Ohio State University - Dayton ...

APOTECA To Engage In A Unique Enterprise Solution For IV Automation At The Ohio State University - Dayton ...

The Business Journals‎ - 35 secs ago

IV Logics is excited to announce that the APOTECA™ integrated Enterprise IVCompounding Solution will be incorporated into The Ohio State University's ..

Top FiercePharma Stories

Today's Top Stories
1. How can reps reach docs? Trying thinking like Netflix or Amazon
2. Sunshine fact: $3.5B + 546,000 docs equals one unwieldy database
3. Pfizer DTC message: Hey guys, women say it's cool to take Viagra
4. Novartis dinner-party kickback case must go on, judge says
5. Sucampo's Amitiza targets 45-plus women with belly-as-balloon DTC ads

Key Quote to Note: The logic then was, as it has remained, that the subtle dangers of defective drugs can often be lethal, and that such dangers will almost invariably be inscrutable to the untutored eye of the consumer or patient.

quoted from article posted earlier this week:

http://digitalcommons.pace.edu/cgi/viewcontent.cgi?article=1253&context=plr

Must Read and Take Note: The misbranding prohibition has sharp teeth. Introducing or delivering a misbranded drug or device is not an intent crime but instead a strict liability misdemeanor, which becomes a felony when there is intent to defraud or mislead.7

http://www.alston.com/Files/Publication/1b057965-7e33-45e2-9fd6-067f36445701/Presentation/PublicationAttachment/be155e11-fa68-4327-acb3-0f19143f76a6/MisbrandingMB.pdf

Open Payments website reveals $3.5 billion paid to docs, hospitals By Jaimy Lee Posted: September 30, 2014 - 8:00 pm ET Tags: Compensation, Devicemakers, Healthcare Reform, Hospitals, Pharmaceuticals, Physicians, Robert Wah

http://www.modernhealthcare.com/article/20140930/NEWS/309309990&utm_source=AltURL&utm_medium=email&utm_campaign=am&AllowView=VXQ0UnpwZTVBL2VlL1IzSkUvSHRlRU9nakV3ZEErOWQ=?mh

Minnesota Board of Pharmacy October 1, 2014 Newsletter--Check out board action against compounding pharmacy for veterinary compounds not being patient-specific

here

Louisiana Board of Pharmacy October 1, 2014 Newsletter-Coverage of Federal and State Law Changes

here

Arizona Board of Pharmacy October 1, 2014 Newsletter

here